Track the Canadian Junior Mining Market at the speed of AI

Build a portfolio of Canadian junior mining companies on 6ix and get real-time updates the minute they announce something. Discover investor events, company profiles, and news in one place.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
7m ago	Adyton Resources Announces Filing of Financial Statements and MD&A for the Three Months Ending March 31, 2026
8m ago	BluMetric Announces Q2 2026 Financial Results
8m ago	ComEd Renewable Energy Investments Help Expand Customer Access to Clean Energy and Lower Costs
8m ago	Avis Budget Group Announces Pricing of $300 Million of Senior Notes
8m ago	NexMetals Announces Results of Annual General Meeting of Shareholders

About

6.06USD+0.04 +0.66%

Closed • Updated at 21:46 GMT+00:00

Market Cap$104.10M

Volume25.9K

Beta5.35

RSI45.22

Gross Margin89.52%

Health TechnologyPharmaceuticals: Major

Verrica Pharmaceuticals Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting

Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026

Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting

Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference

Recent Videos

Verrica Pharmaceuticals (VRCA|$90.8M) - 2025 Q4 & Full Year Earnings Analysis

Verrica Pharmaceuticals (VRCA|$90.8M) - 2025 Q4 & Full Year Earnings Analysis

Mar 11, 2026

VRCA STOCK : POTENTIAL UPMOVE | VERRICA PHARMACEUTICALS STOCK

VRCA STOCK : POTENTIAL UPMOVE | VERRICA PHARMACEUTICALS STOCK

Mar 03, 2026

Cómo comprar acciones de Verrica Pharmaceuticals Inc (VRCA)

Cómo comprar acciones de Verrica Pharmaceuticals Inc (VRCA)

Feb 28, 2026

Verrica Pharmaceuticals Inc VRCA Q3 2025 Earnings Call

Verrica Pharmaceuticals Inc VRCA Q3 2025 Earnings Call

Dec 03, 2025

Community Chat

Ask AI

Try asking